CP-LC-1422
CP-LC-1422 is a homocysteine-derived ionizable amino lipid with high RNA delivery capability and can mediate high-level protein expression in vivo. CP-LC-1422 exhibits significant spleen targeting via intravenous injection in a lipid nanoparticle (LNP) formulation with no significant toxicity observed[1].
Product Specifications
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
O=C(C(NC(CCCCC(SCCC(OCCCCCC(C)C)=O)CCSCCC(OCCCCCC(C)C)=O)=O)CCSCCC(OCCCCCCCC(C)C)=O)NCCN(C)C
Molecular Formula
C51H97N3O8S3
Molecular Weight
976.53
References & Citations
[1]Jörgensen AM, et al. Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients. Small. 2023 Apr;19 (17) :e2206968.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942884-100 1x 100 µL
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-C075310-10MG 10 mg
5beta-Cholestane-3alpha,7alpha,12alpha,24beta,25-pentol
Sign In for Pricing
View Details 
TRC-I821853-2.5MG 2.5 mg
Isopentenyl Pyrophosphate Ammonium Salt-13C2 (Contains ~1eq H3PO4)
Sign In for Pricing
View Details 
BNUB1758-500 1x 500 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1758), 0.2mg/mL
Sign In for Pricing
View Details